Your browser is no longer supported. Please, upgrade your browser.
DHR Danaher Corporation daily Stock Chart
DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E52.25 EPS (ttm)4.16 Insider Own0.40% Shs Outstand710.90M Perf Week-3.33%
Market Cap154.36B Forward P/E30.32 EPS next Y7.16 Insider Trans-13.45% Shs Float630.29M Perf Month-9.41%
Income2.99B PEG3.45 EPS next Q1.83 Inst Own81.70% Short Float0.95% Perf Quarter6.28%
Sales18.36B P/S8.41 EPS this Y-2.20% Inst Trans0.22% Short Ratio2.50 Perf Half Y30.38%
Book/sh48.80 P/B4.45 EPS next Y18.88% ROA5.20% Target Price263.75 Perf Year48.80%
Cash/sh8.00 P/C27.14 EPS next 5Y15.14% ROE11.30% 52W Range119.60 - 248.32 Perf YTD41.53%
Dividend0.72 P/FCF39.39 EPS past 5Y7.60% ROI4.70% 52W High-12.70% Beta0.77
Dividend %0.33% Quick Ratio1.70 Sales past 5Y6.80% Gross Margin55.00% 52W Low81.25% ATR6.48
Employees60000 Current Ratio2.10 Sales Q/Q34.40% Oper. Margin21.30% RSI (14)37.70 Volatility2.66% 2.86%
OptionableYes Debt/Eq0.63 EPS Q/Q38.80% Profit Margin19.40% Rel Volume0.63 Prev Close217.22
ShortableYes LT Debt/Eq0.63 EarningsOct 22 BMO Payout13.90% Avg Volume2.41M Price216.78
Recom1.70 SMA20-5.86% SMA50-3.21% SMA20017.46% Volume1,405,407 Change-0.20%
Nov-25-20Downgrade RBC Capital Mkts Outperform → Sector Perform $273 → $234
Nov-10-20Initiated KeyBanc Capital Markets Overweight $280
Jun-16-20Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20Downgrade Wolfe Research Outperform → Peer Perform $154
Mar-26-20Upgrade RBC Capital Mkts Sector Perform → Outperform $151 → $157
Feb-03-20Reiterated Needham Buy $167 → $187
Jan-08-20Initiated Wells Fargo Overweight $170
Jan-07-20Initiated Citigroup Buy $180
Nov-15-19Resumed Stifel Hold
Oct-28-19Reiterated Needham Buy $155 → $152
Oct-14-19Resumed Credit Suisse Outperform $151
Jul-19-19Reiterated Needham Buy $142 → $155
Jun-11-19Initiated Piper Jaffray Neutral
May-30-19Initiated Wolfe Research Outperform
Apr-17-19Reiterated Needham Buy $138 → $141
Feb-28-19Reiterated Needham Buy $114 → $138
Feb-25-19Upgrade Janney Neutral → Buy
Jan-03-19Initiated Needham Buy $114
Apr-20-18Reiterated Stifel Buy $108 → $114
Feb-15-18Initiated Barclays Overweight $110
Nov-27-20 01:08PM  
Nov-25-20 03:49PM  
Nov-24-20 05:48PM  
05:00PM  
Nov-23-20 09:13AM  
08:00AM  
Nov-22-20 02:10AM  
Nov-21-20 11:30AM  
Nov-20-20 07:37AM  
Nov-17-20 09:13AM  
Nov-16-20 04:15PM  
Nov-15-20 09:51PM  
Nov-11-20 01:56PM  
Nov-10-20 04:15PM  
03:00AM  
Nov-06-20 01:12PM  
Nov-04-20 07:35AM  
Nov-02-20 10:51AM  
Oct-30-20 07:37AM  
Oct-29-20 12:20PM  
Oct-28-20 12:31PM  
Oct-27-20 08:22AM  
07:49AM  
04:00AM  
Oct-26-20 11:51PM  
Oct-23-20 09:51AM  
Oct-22-20 04:24PM  
01:00PM  
10:52AM  
09:14AM  
07:30AM  
07:18AM  
06:00AM  
Oct-21-20 10:12AM  
09:48AM  
09:19AM  
07:55AM  
Oct-20-20 12:39PM  
12:00PM  
11:40AM  
Oct-19-20 12:58PM  
11:07AM  
Oct-17-20 10:38AM  
04:53AM  
Oct-16-20 07:29AM  
Oct-15-20 12:32PM  
08:00AM  
Oct-14-20 08:36AM  
Oct-12-20 10:45AM  
Oct-09-20 08:00AM  
Oct-07-20 04:15PM  
12:10PM  
10:40AM  
Oct-06-20 08:54AM  
07:00AM  
Oct-02-20 11:40AM  
Sep-30-20 09:41AM  
09:06AM  
Sep-29-20 09:30PM  
03:09PM  
09:09AM  
07:00AM  
Sep-28-20 11:32AM  
05:30AM  
Sep-27-20 07:47AM  
Sep-25-20 05:45PM  
11:15AM  
08:38AM  
Sep-18-20 08:58AM  
06:09AM  
Sep-17-20 07:18PM  
09:07AM  
Sep-15-20 04:15PM  
09:00AM  
09:00AM  
Sep-13-20 03:00PM  
03:00PM  
Sep-03-20 08:00AM  
Sep-02-20 02:36PM  
Sep-01-20 04:15PM  
Aug-28-20 05:50PM  
03:05PM  
01:05PM  
Aug-27-20 09:40AM  
Aug-25-20 01:59PM  
Aug-24-20 08:00AM  
Aug-22-20 11:30AM  
07:45AM  
Aug-18-20 11:26AM  
10:35AM  
Aug-14-20 09:13AM  
Aug-10-20 08:00AM  
Aug-07-20 12:24PM  
Aug-02-20 10:53AM  
Jul-31-20 12:58PM  
12:25PM  
Jul-30-20 09:50AM  
Jul-29-20 12:20PM  
Jul-28-20 12:00PM  
Jul-27-20 07:00AM  
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RALES MITCHELL PChairman of Exec. CommitteeNov 19Buy226.1426,7846,056,9342,404,658Nov 23 07:41 PM
Zerhouni Elias A.DirectorNov 03Option Exercise38.398,898341,55738,109Nov 04 05:26 PM
Zerhouni Elias A.DirectorNov 03Sale233.718,8982,079,59433,561Nov 04 05:26 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Option Exercise46.1324,5941,134,52143,544Oct 27 05:14 PM
COMAS DANIEL LEVPOct 23Option Exercise65.8354,4023,581,284130,161Oct 27 05:13 PM
Raskas DanielSVP-Corporate DevelopmentOct 23Option Exercise40.4528,3891,148,33538,850Oct 27 05:14 PM
Raskas DanielSVP-Corporate DevelopmentOct 23Sale234.5028,3896,657,17719,723Oct 27 05:14 PM
COMAS DANIEL LEVPOct 23Sale233.2554,40212,689,03792,683Oct 27 05:13 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Sale233.1924,5945,735,03918,950Oct 27 05:14 PM
Lalor Angela SSVP, Human ResourcesAug 31Option Exercise57.2138,9552,228,59158,330Sep 01 05:45 PM
Lalor Angela SSVP, Human ResourcesAug 31Sale206.0038,9558,024,73035,910Sep 01 05:45 PM
Lalor Angela SSVP, Human ResourcesAug 28Option Exercise57.2138,9542,228,53458,329Sep 01 05:45 PM
Lalor Angela SSVP, Human ResourcesAug 28Sale205.0038,9547,985,57035,910Sep 01 05:45 PM
McGrew MatthewEVP & Chief Financial OfficerJul 29Sale203.427,4571,516,92512,387Jul 30 07:13 PM
King WilliamSVP, Strategic DevelopmentJul 28Option Exercise54.3126,9821,465,36740,339Jul 29 05:11 PM
King WilliamSVP, Strategic DevelopmentJul 28Sale199.0926,9825,371,87821,589Jul 29 05:11 PM
LOHR WALTER GDirectorJul 28Sale198.5657,00011,317,692391,000Jul 29 05:10 PM
HEFNER LINDA PDirectorJul 27Option Exercise28.9811,014319,18638,255Jul 28 06:13 PM
Zerhouni Elias A.DirectorJul 27Option Exercise28.9811,014319,18634,809Jul 28 06:17 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Option Exercise36.8719,834731,280112,548Jul 28 06:16 PM
HEFNER LINDA PDirectorJul 27Sale197.002,754542,53829,995Jul 28 06:13 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Sale196.0019,8343,887,46492,714Jul 28 06:16 PM
COMAS DANIEL LEVPJul 27Sale200.878,0001,606,93796,933Jul 28 06:12 PM
COMAS DANIEL LEVPJul 24Option Exercise59.7888,9785,318,953163,911Jul 28 06:12 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Option Exercise65.90181,39411,953,088302,851Jul 28 06:13 PM
SCHWIETERS JOHN TDirectorJul 24Option Exercise28.9811,014319,18625,394Jul 28 06:15 PM
SCHWIETERS JOHN TDirectorJul 24Sale193.956,0141,166,40319,380Jul 28 06:15 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Sale193.98181,39435,186,837203,513Jul 28 06:13 PM
COMAS DANIEL LEVPJul 24Sale195.273,054596,3910Jul 28 06:12 PM
COMAS DANIEL LEVPJul 24Sale193.9788,97817,258,652104,933Jul 28 06:12 PM
RALES MITCHELL PChairman of Exec. CommitteeMay 29Buy164.69141,42023,291,0852,377,874Jun 02 04:30 PM
LOHR WALTER GDirectorMay 28Option Exercise28.9811,014319,18622,392May 29 05:11 PM
Blair RainerExecutive Vice PresidentMay 28Sale165.963,330552,63736,256May 29 05:13 PM
LOHR WALTER GDirectorMay 28Sale165.6111,0141,824,02911,378May 29 05:11 PM
COMAS DANIEL LEVPMay 18Sale165.6818,2593,025,078104,933May 19 05:11 PM
RALES MITCHELL PChairman of Exec. CommitteeMay 12Buy163.001,226199,8382,256May 12 04:12 PM
Raskas DanielSVP-Corporate DevelopmentMay 08Option Exercise37.5129,0111,088,20348,734May 12 05:30 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 08Option Exercise40.4528,3891,148,33547,339May 12 05:29 PM
Raskas DanielSVP-Corporate DevelopmentMay 08Sale164.0937,0826,084,92919,723May 12 05:30 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 08Sale161.6833,8925,479,69618,950May 12 05:29 PM
Lalor Angela SSVP, Human ResourcesMay 08Sale163.038,0311,309,27035,910May 12 05:27 PM
Ellis Brian WSVP, GC & CCOMay 08Sale163.402,870468,96924,837May 12 05:27 PM
SPOON ALAN GDirectorMar 20Option Exercise33.1819,912660,742111,293Mar 23 05:19 PM
DANIEL WILLIAM KEVPMar 04Sale147.5406594,384Mar 06 05:10 PM
King WilliamSVP, Strategic DevelopmentFeb 20Option Exercise44.0323,8081,048,23434,865Feb 24 06:21 PM
King WilliamSVP, Strategic DevelopmentFeb 20Sale160.2326,3704,225,19119,865Feb 24 06:21 PM
EHRLICH DONALD JDirectorFeb 10Option Exercise28.986,014174,286129,217Feb 11 05:51 PM
DANIEL WILLIAM KEVPFeb 10Sale163.2320,7333,384,31688,986Feb 12 05:13 PM
EHRLICH DONALD JDirectorFeb 10Sale163.136,014981,034123,203Feb 11 05:51 PM
Joyce Thomas Patrick JRPresident and CEOFeb 07Sale162.0320,4923,320,257157,694Feb 11 05:50 PM
COMAS DANIEL LEVPFeb 04Option Exercise56.7050,0002,835,000156,479Feb 05 08:43 PM
COMAS DANIEL LEVPFeb 04Sale163.2650,0008,162,950106,479Feb 05 08:43 PM
COMAS DANIEL LEVPFeb 03Option Exercise56.703,100175,770108,579Feb 04 08:46 PM
Lalor Angela SSVP, Human ResourcesFeb 03Option Exercise46.1318,267842,65756,782Feb 04 08:51 PM
McGrew MatthewEVP & Chief Financial OfficerFeb 03Option Exercise40.457,894319,31229,214Feb 04 08:53 PM
McGrew MatthewEVP & Chief Financial OfficerFeb 03Sale161.9811,3041,831,03021,320Feb 04 08:53 PM
Lalor Angela SSVP, Human ResourcesFeb 03Sale161.4918,2672,949,84638,515Feb 04 08:51 PM
COMAS DANIEL LEVPFeb 03Sale161.343,100500,167106,479Feb 04 08:46 PM
Blair RainerExecutive Vice PresidentJan 31Option Exercise57.1033,4671,910,81349,752Feb 04 08:45 PM
COMAS DANIEL LEVPJan 31Option Exercise57.9079,3644,595,176188,583Feb 04 08:46 PM
Joyce Thomas Patrick JRPresident and CEOJan 31Option Exercise62.82132,4748,321,445277,663Feb 04 08:49 PM
Joyce Thomas Patrick JRPresident and CEOJan 31Sale162.51132,47421,527,890195,608Feb 04 08:49 PM
COMAS DANIEL LEVPJan 31Sale161.5079,36412,817,492115,442Feb 04 08:46 PM
Blair RainerExecutive Vice PresidentJan 31Sale163.5036,4405,957,88127,313Feb 04 08:45 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.